Last Updated: May 20, 2026

CLINICAL TRIALS PROFILE FOR CEFTAZIDIME

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Ceftazidime

Subscribe to access the full database, or Start Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00173901 ↗	Adverse Drug Reactions of Different Brands of Ceftazidime Injection	Unknown status	National Taiwan University Hospital	Phase 4	2001-03-01	The purpose of this study is to understand whether generic ceftazidime causes different adverse drug reaction incidence from the brand drug.
NCT00210964 ↗	Ceftobiprole in Hospital Acquired Pneumonia	Completed	Basilea Pharmaceutica	Phase 3	2005-04-01	The purpose of this study is to compare the clinical cure rate of ceftobiprole medocaril (the water-soluble prodrug [form] of ceftobiprole) referred to as ceftobiprole versus a comparator in the treatment of patients with nosocomial pneumonia.
NCT00229008 ↗	Ceftobiprole in Hospital Acquired Pneumonia	Completed	Basilea Pharmaceutica	Phase 3	2005-11-01	The purpose of this study is to compare the clinical cure rate of ceftobiprole medocaril (the water-soluble prodrug [form] of ceftobiprole) referred to as ceftobiprole versus a comparator in the treatment of patients with nosocomial pneumonia.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Ceftazidime

Condition Name

Chart
Table

Condition Name for Ceftazidime
Intervention	Trials
Pneumonia	5
Cystic Fibrosis	5
Complicated Intra-abdominal Infection	4
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Ceftazidime
Intervention	Trials
Infections	21
Infection	18
Communicable Diseases	17
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Ceftazidime

Trials by Country

Map
Table

Trials by Country for Ceftazidime
Location	Trials
United States	94
China	27
Japan	18
India	14
Spain	13
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Ceftazidime
Location	Trials
California	12
Ohio	9
Michigan	6
Florida	5
Texas	5
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Ceftazidime

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Ceftazidime
Clinical Trial Phase	Trials
PHASE4	4
PHASE3	3
PHASE2	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Ceftazidime
Clinical Trial Phase	Trials
Completed	38
Recruiting	15
Unknown status	10
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Ceftazidime

Sponsor Name

Chart
Table

Sponsor Name for Ceftazidime
Sponsor	Trials
Pfizer	24
AstraZeneca	17
Forest Laboratories	7
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Ceftazidime
Sponsor	Trials
Industry	71
Other	67
UNKNOWN	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.